Fineline Cube

Follow:
14409 Articles
3SBio HK$3.1B Placement Funds R&D Pipeline for 705, 706, 008
CompanyDeals

3SBio HK$3.1B Placement Funds R&D Pipeline for 705, 706, 008

Generate GB-0895 Asthma Phase III Trials to Enroll 1,600 Patients
CompanyDrug

Generate GB-0895 Asthma Phase III Trials to Enroll 1,600 Patients

Henlius HLX14 Denosumab Biosimilar NDA Accepted by China CDE
CompanyDrug

Henlius HLX14 Denosumab Biosimilar NDA Accepted by China CDE

New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals
CompanyDeals

New-Radiomedicine Series-D Raises 800M Yuan for Radiopharmaceuticals

Kura ziftomenib Sale Triggers $135M Kyowa-Kirin Payment
CompanyDeals

Kura ziftomenib Sale Triggers $135M Kyowa-Kirin Payment

Roche cobas-liat Whooping-Cough Test Secures FDA Clearance
CompanyMedical Device

Roche cobas-liat Whooping-Cough Test Secures FDA Clearance

Henlius HLX37 Bispecific NMPA Approval Targets Advanced Solid Tumors
CompanyDrug

Henlius HLX37 Bispecific NMPA Approval Targets Advanced Solid Tumors

Leads-Biolabs LBL047 Bispecific Secures China IND Approval for SLE
CompanyDrug

Leads-Biolabs LBL047 Bispecific Secures China IND Approval for SLE

Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline
CompanyDeals

Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline

Abbisko ABSK141 KRAS-G12D Inhibitor Secures FDA IND Approval
CompanyDrug

Abbisko ABSK141 KRAS-G12D Inhibitor Secures FDA IND Approval

AbbVie Rinvoq upadacitinib CDE Priority Review Alopecia Areata China
CompanyDrug

AbbVie Rinvoq upadacitinib CDE Priority Review Alopecia Areata China

Lynk Pharma LNK01006 FDA Approval Targets TYK2 for CNS Diseases
CompanyDrug

Lynk Pharma LNK01006 FDA Approval Targets TYK2 for CNS Diseases